194 related articles for article (PubMed ID: 21047569)
1. Distinct mechanisms are responsible for osteopenia and growth retardation in OASIS-deficient mice.
Murakami T; Hino S; Nishimura R; Yoneda T; Wanaka A; Imaizumi K
Bone; 2011 Mar; 48(3):514-23. PubMed ID: 21047569
[TBL] [Abstract][Full Text] [Related]
2. Effects of the bisphosphonate risedronate on osteopenia in OASIS-deficient mice.
Sekiya H; Murakami T; Saito A; Hino S; Tsumagari K; Ochiai K; Imaizumi K
J Bone Miner Metab; 2010 Jul; 28(4):384-94. PubMed ID: 20024590
[TBL] [Abstract][Full Text] [Related]
3. Roles of the endoplasmic reticulum stress transducer OASIS in fracture healing.
Funamoto T; Sekimoto T; Murakami T; Kurogi S; Imaizumi K; Chosa E
Bone; 2011 Oct; 49(4):724-32. PubMed ID: 21708301
[TBL] [Abstract][Full Text] [Related]
4. Signalling mediated by the endoplasmic reticulum stress transducer OASIS is involved in bone formation.
Murakami T; Saito A; Hino S; Kondo S; Kanemoto S; Chihara K; Sekiya H; Tsumagari K; Ochiai K; Yoshinaga K; Saitoh M; Nishimura R; Yoneda T; Kou I; Furuichi T; Ikegawa S; Ikawa M; Okabe M; Wanaka A; Imaizumi K
Nat Cell Biol; 2009 Oct; 11(10):1205-11. PubMed ID: 19767743
[TBL] [Abstract][Full Text] [Related]
5. Increased vulnerability of hippocampal pyramidal neurons to the toxicity of kainic acid in OASIS-deficient mice.
Chihara K; Saito A; Murakami T; Hino S; Aoki Y; Sekiya H; Aikawa Y; Wanaka A; Imaizumi K
J Neurochem; 2009 Aug; 110(3):956-65. PubMed ID: 19549009
[TBL] [Abstract][Full Text] [Related]
6. Physiological unfolded protein response regulated by OASIS family members, transmembrane bZIP transcription factors.
Kondo S; Saito A; Asada R; Kanemoto S; Imaizumi K
IUBMB Life; 2011 Apr; 63(4):233-9. PubMed ID: 21438114
[TBL] [Abstract][Full Text] [Related]
7. Wdr5, a WD-40 protein, regulates osteoblast differentiation during embryonic bone development.
Gori F; Friedman LG; Demay MB
Dev Biol; 2006 Jul; 295(2):498-506. PubMed ID: 16730692
[TBL] [Abstract][Full Text] [Related]
8. A transgenic model to determine the physiological role of liver-derived insulin-like growth factor I.
Sjögren K; Jansson JO; Isaksson OG; Ohlsson C
Minerva Endocrinol; 2002 Dec; 27(4):299-311. PubMed ID: 12511852
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitous overexpression of Hey1 transcription factor leads to osteopenia and chondrocyte hypertrophy in bone.
Salie R; Kneissel M; Vukevic M; Zamurovic N; Kramer I; Evans G; Gerwin N; Mueller M; Kinzel B; Susa M
Bone; 2010 Mar; 46(3):680-94. PubMed ID: 19857617
[TBL] [Abstract][Full Text] [Related]
10. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage.
Kalajzic I; Kalajzic Z; Kaliterna M; Gronowicz G; Clark SH; Lichtler AC; Rowe D
J Bone Miner Res; 2002 Jan; 17(1):15-25. PubMed ID: 11771662
[TBL] [Abstract][Full Text] [Related]
11. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.
Li J; Sarosi I; Cattley RC; Pretorius J; Asuncion F; Grisanti M; Morony S; Adamu S; Geng Z; Qiu W; Kostenuik P; Lacey DL; Simonet WS; Bolon B; Qian X; Shalhoub V; Ominsky MS; Zhu Ke H; Li X; Richards WG
Bone; 2006 Oct; 39(4):754-66. PubMed ID: 16730481
[TBL] [Abstract][Full Text] [Related]
12. Tunicamycin negatively regulates BMP2-induced osteoblast differentiation through CREBH expression in MC3T3E1 cells.
Jang WG; Kim EJ; Koh JT
BMB Rep; 2011 Nov; 44(11):735-40. PubMed ID: 22118540
[TBL] [Abstract][Full Text] [Related]
13. Cloning and functional analysis of a family of nuclear matrix transcription factors (NP/NMP4) that regulate type I collagen expression in osteoblasts.
Thunyakitpisal P; Alvarez M; Tokunaga K; Onyia JE; Hock J; Ohashi N; Feister H; Rhodes SJ; Bidwell JP
J Bone Miner Res; 2001 Jan; 16(1):10-23. PubMed ID: 11149472
[TBL] [Abstract][Full Text] [Related]
14. Col1a1-driven transgenic markers of osteoblast lineage progression.
Dacic S; Kalajzic I; Visnjic D; Lichtler AC; Rowe DW
J Bone Miner Res; 2001 Jul; 16(7):1228-36. PubMed ID: 11450698
[TBL] [Abstract][Full Text] [Related]
15. Bone-targeted overexpression of Bcl-2 increases osteoblast adhesion and differentiation and inhibits mineralization in vitro.
Zhang W; Pantschenko AG; McCarthy MB; Gronowicz G
Calcif Tissue Int; 2007 Feb; 80(2):111-22. PubMed ID: 17308993
[TBL] [Abstract][Full Text] [Related]
16. Fidgetin-like 1 gene inhibited by basic fibroblast growth factor regulates the proliferation and differentiation of osteoblasts.
Park SJ; Kim SJ; Rhee Y; Byun JH; Kim SH; Kim MH; Lee EJ; Lim SK
J Bone Miner Res; 2007 Jun; 22(6):889-96. PubMed ID: 17352653
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
18. OASIS is a transcriptional activator of CREB/ATF family with a transmembrane domain.
Omori Y; Imai J; Suzuki Y; Watanabe S; Tanigami A; Sugano S
Biochem Biophys Res Commun; 2002 Apr; 293(1):470-7. PubMed ID: 12054625
[TBL] [Abstract][Full Text] [Related]
19. Comparison of expression patterns between CREB family transcription factor OASIS and proteoglycan core protein genes during murine tooth development.
Hikake T; Mori T; Iseki K; Hagino S; Zhang Y; Takagi H; Yokoya S; Wanaka A
Anat Embryol (Berl); 2003 Apr; 206(5):373-80. PubMed ID: 12684764
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
